236395-14-5 98%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:10kg
- Time:2024-01-08
Product Details
- Product NameEslicarbazepine Acetate
- CAS No.236395-14-5
- EINECS No.636-617-2
- MFC17H16N2O3
- MW296.32
- Appearancesolidwhite
- storage temp. Sealed in dry,2-8°C
- density 1.32
- Melting point 183-185°C
- Boiling point 427.4±55.0 °C(Predicted)
Company Profile Introduction
We are one of world’s leading producers of key Active Pharmaceutical Ingredients (APIs) and generic formulations with presence in 140+ countries and backed by 30 years of experience in the pharma sector. We endeavour to serve patients by moulding science and technology into therapies to improve health outcomes and people’s lives.
We leverage our experience of 30 years in developing APIs across diverse therapeutic areas and are a leading supplier to generics manufacturers. We are among the first Indian companies to develop and manufacture affordable APIs for ARVs. Our portfolio includes over 300 APIs across multiple therapeutic segments.
Supplier other products
Recommended supplier
-
VIP1年
- Flowchem Pharma Pvt Ltd
- 236395-14-5 98%
- Inquiry
- 2024-03-29
-
VIP1年
- Amoli Organics Pvt Ltd
- Eslicarbazepine Acetate 98%
- Inquiry
- 2024-03-20
-
VIP1年
- Ami Lifesciences Pvt Ltd
- 236395-14-5 Eslicarbazepine Acetate 99%
- Inquiry
- 2024-02-17
-
VIP1年
- Alfa Omega Pharma
- Eslicarbazepine Acetate 236395-14-5 98%
- Inquiry
- 2024-02-17
-
VIP1年
- Ralington Pharma
- Eslicarbazepine Acetate 98%
- Inquiry
- 2024-02-05
-
VIP1年
- Narmada Organics
- 236395-14-5 98%
- Inquiry
- 2024-02-02
-
VIP1年
- Besil Chem LLP
- 236395-14-5 Eslicarbazepine Acetate 98%
- Inquiry
- 2024-01-29
-
VIP1年
- Assurgen Pharma Pvt Ltd
- Eslicarbazepine Acetate 236395-14-5 99%
- Inquiry
- 2024-01-24
-
VIP1年
- Aruvi Labs
- Eslicarbazepine Acetate 98%
- Inquiry
- 2024-01-16
-
VIP1年
- ZCL Chemicals Ltd
- 236395-14-5 98%
- Inquiry
- 2024-01-12
- Since:2020-01-01
- Address: "7-2-A2, Hetero Corporate Industrial Estates, Sanath Nagar Hyderabad Telangana"